Who owns APREA THERAPEUTICS INC?
- Ticker: APRE
- CUSIP Number: 03836j201
Tip: Access positions for across all investors
Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aprea Therapeutics stock
Who bought or sold APREA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 539k | $796k | 0% | Sep 2025 |
|
| Sphera Funds Management | 270k | $398k | 0% | Sep 2025 |
|
| Nantahala Capital Management | 206k | $304k | 0% | Sep 2025 |
|
| Vanguard Group | 158k | $233k | -9% | Sep 2025 |
|
| DAFNA Capital Management | 137k | $202k | 0% | Sep 2025 |
|
| Sio Capital Management | 112k | $166k | -60% | Sep 2025 |
|
| Morgan Stanley | 63k | $107k | 100% | Jun 2025 |
|
| Geode Capital Management | 45k | $66k | 3% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $25k | 11% | Sep 2025 |
|
| LPL Financial | 16k | $24k | -6% | Sep 2025 |
|
| HighTower Advisors | 14k | $20k | 0% | Sep 2025 |
|
| Hrt Financial | 12k | $18k | 100% | Sep 2025 |
|
| Landscape Capital Management | 11k | $16k | -56% | Sep 2025 |
|
| BlackRock | 8.5k | $13k | 0% | Sep 2025 |
|
| Mb, Levis & Associates | 806.00 | $1.2k | 0% | Sep 2025 |
|
| Group One Trading | 577.00 | $851.017300 | 0% | Sep 2025 |
|
| Tower Research Capital | 568.00 | $838.027200 | -81% | Sep 2025 |
|
| Advisor Group Holdings | 400.00 | $609.000000 | 0% | Sep 2025 |
|
| WealthCollab | 158.00 | $233.998000 | 0% | Sep 2025 |
|
| SBI Securities | 42.00 | $62.000400 | 5% | Sep 2025 |
|
| UBS Group | 3.00 | $3.999900 | -62% | Sep 2025 |
|
Who sold out of Aprea Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Dimensional Fund Advisors | Jun 2025 | 15k | $25k |
| FMR | Jun 2025 | 501.00 | $852.000600 |
| Jpmorgan Chase & Co | Mar 2025 | 10.00 | $20.000000 |